Young Choi to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Young Choi has written about Drug Evaluation, Preclinical.
Connection Strength
0.100
-
Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein. Int J Antimicrob Agents. 2018 Nov; 52(5):730-732.
Score: 0.080
-
Preclinical evaluation of the efficacy of an H5N8 vaccine candidate (IDCDC-RG43A) in mouse and ferret models for pandemic preparedness. Vaccine. 2019 01 14; 37(3):484-493.
Score: 0.020